scholarly journals Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6%

PLoS ONE ◽  
2020 ◽  
Vol 15 (8) ◽  
pp. e0237603
Author(s):  
Heleen H. DeCory ◽  
Christine M. Sanfilippo ◽  
Howard M. Proskin ◽  
Joseph M. Blondeau
Keyword(s):  
Bacterial Conjunctivitis ◽  
Randomized Controlled ◽  
Ophthalmic Suspension

scholarly journals Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata

2020 ◽  
Vol 10 (2) ◽  
pp. 110
Author(s):  
Prithwijit Banerjee ◽  
Mita Chowdhury ◽  
Souradeep Ray ◽  
Soumya Chatterjee ◽  
Shreshtha Basak ◽  
...  
Keyword(s):  
Eye Drops ◽  
Open Label ◽  
Bacterial Conjunctivitis ◽  
Randomized Controlled ◽  
Acute Bacterial Conjunctivitis

scholarly journals Translational Research in Intensive Care Unit: Novel Approaches for Drug Development and Personalized Medicine

2019 ◽  
Vol 40 (05) ◽  
pp. 687-698
Author(s):  
Romit J. Samanta ◽  
Charlotte Summers
Keyword(s):  
Distress Syndrome ◽  
Controlled Trials ◽  
Randomized Controlled ◽  
Clinical Syndromes ◽  
Clinical Presentations ◽  
Novel Approaches ◽  
And Personalized Medicine ◽  
Insight Into ◽  
Made In

AbstractThe major clinical presentations seen by critical care physicians are sepsis and acute respiratory distress syndrome (ARDS), both of which are heterogeneous clinical syndromes rather than specific diagnoses. The current diagnostic criteria provide little insight into the mechanisms underlying these heterogeneous syndromes and minimal progress has been made with regard to the development of therapies, despite many large randomized controlled trials being undertaken. This review outlines the advances made in improved characterization of critically-ill patients, using ARDS as an exemplar, and highlights the need for this improved patient characterization to be coupled with mechanistic science to develop therapies that target specific pathomechanisms.

Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies

2014 ◽  
Vol 262 (6) ◽  
pp. 1401-1406 ◽  
Author(s):  
Fabio Giovannelli ◽  
Gaetano Zaccara ◽  
Massimo Cincotta ◽  
Giulia Loiacono ◽  
Alberto Verrotti
Keyword(s):  
Adverse Events ◽  
Randomized Controlled Trials ◽  
Controlled Trials ◽  
Drug Resistant ◽  
Randomized Controlled

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis

2009 ◽  
Vol 25 (5) ◽  
pp. 1159-1169 ◽  
Author(s):  
Michael E. Tepedino ◽  
Warren H. Heller ◽  
Dale W. Usner ◽  
Lynne S. Brunner ◽  
Timothy W. Morris ◽  
...  
Keyword(s):  
Phase Iii ◽  
Efficacy And Safety ◽  
Bacterial Conjunctivitis ◽  
Safety Study ◽  
Ophthalmic Suspension

Characterization of published randomized controlled trials assessing clinical pharmacy services around the world

2017 ◽  
Vol 13 (1) ◽  
pp. 201-208 ◽  
Author(s):  
Inajara Rotta ◽  
Thais Teles Souza ◽  
Teresa M. Salgado ◽  
Cassyano J. Correr ◽  
Fernando Fernandez-Llimos
Keyword(s):  
Randomized Controlled Trials ◽  
Clinical Pharmacy ◽  
Controlled Trials ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Randomized Controlled ◽  
The World
Sign in / Sign up

Export Citation Format

Share Document